Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ImClone, Bristol-Myers withdraw FDA application for Erbitux use in a type of lung cancer
ImClone, Bristol-Myers withdraw FDA application for Erbitux use in a type of lung cancer
ImClone, Bristol-Myers withdraw FDA application for Erbitux use in a type of lung cancer
Submitted by
admin
on January 24, 2009 - 10:28am
Source:
Yahoo/AP
News Tags:
ImClone
Bristol-Myers Squibb
lung cancer
Erbitux
Headline:
ImClone, Bristol-Myers withdraw FDA application for Erbitux use in a type of lung cancer
Do Not Allow Advertisers to Use My Personal information
